# Vivestnet

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/vivestnet

- Industry: Medical Devices & Equipment
- Headquarters: Suzhou, China
- Website: www.vivest.cn
- Total disclosed funding: $15M
- Latest round: Series A (Jun 9, 2021)
- Investors on record: 5

## About

Established in 2019 and based in Suzhou, China, Vivestnet is a medical technology company that focuses ventricular arrhythmia prevention, and control and heart rhythm data services. In 2021, the company was approved for PowerBeat X1/X3 AED registration. In January 2022, Shandong Blue Sail Plastic and Rubber Co.,Ltd. became the strategic partner of the company.

The company provides non-invasive ventricular arrhythmia and sudden cardiac death prevention platform. The platform provides ventricular arrhythmia prevention, monitoring, treatment and rehabilitation solutions. Its products include wearable automated external defibrillators (WCD) and semi-automated external defibrillators (AED). It also provides heart rhythm data services, including automated external defibrillator (AED) remote management system.

## Funding rounds

- Series A, Jun 9, 2021 — NLVC, Oriza Holdings, Bluesail Medical, Broad Vision Funds
- Series A, Apr 19, 2021, $15M — NLVC, Bluesail Medical, Broad Vision Funds
- Angel, Apr 2, 2020 — Lotus Lake Capital

## Investors

- Lotus Lake Capital (https://capitalatlas.ai/funds/lotus-lake-capital) — Angel
- NLVC (https://capitalatlas.ai/funds/nlvc) — Series A
- Bluesail Medical — Series A
- Broad Vision Funds (https://capitalatlas.ai/funds/broad-vision-funds) — Series A
- Oriza Holdings (https://capitalatlas.ai/funds/oriza-holdings) — Series A